# Srđan Verstovšek

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sr-an-verstovsek/

## Facts

| Field | Value |
| --- | --- |
| Citations | 59,248 |
| Field | Myeloproliferative Neoplasms: Diagnosis and Treatment |
| h-index | 115 |
| i10-index | 703 |
| Last Known Institution | Karus Therapeutics (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5085521139 |
| ORCID iD | https://orcid.org/0000-0002-6912-8569 |
| Works | 1,624 |

## Researcher papers

- [Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I](https://scholariq.org/papers/efficacy-safety-and-survival-with-ruxolitinib-in-patients-with-myelofibrosis/)
- [A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis](https://scholariq.org/papers/a-pooled-analysis-of-overall-survival-in-comfort-i-and-comfort-ii-2-randomized/)

## Researcher topics

- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [Karus Therapeutics (United Kingdom)](https://scholariq.org/institutions/karus-therapeutics-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.